Gregory Blaschke, M.D., M.P.H. joins the American Medical Association's COVID-19 update panel to discuss the impact of COVID-19 on children.

The Oregon Health Authority reports that a healthy 29-year-old Multnomah County resident died from COVID-19 at OHSU.

In a story on COVID-19 survivors fearing reinfection, Mary Moffitt, Ph.D., says: “This may not represent the ‘worst-case scenario,’ although that may be the initial reaction of patients traumatized by this virus. Focusing on what we can control today, attending to what we need to improve our well-being here and now, is the most effective strategy to cope with future uncertainty.”

In an article on cost-effective treatment options for patients with prostate cancer, Tom Beer, M.D., says “It’s quite reassuring that the quality-of-life years achieved and the total costs of care are quite similar across the choices.”

OHSU is part of a national study on the use of convalescent plasma to help treat COVID-19, and is seeking COVID-19 patients willing to be part of the study.

Phoebe Rich, M.D., explains how some common nail conditions can be associated with health issues ranging from melanoma to anemia.

OHSU ends COVID-19 study, supports ongoing conversations between Black, Indigenous, and People of Color (BIPOC) Decolonizing Research and Data Council and Governor’s office to better understand disproportionate impacts of the virus within communities of color.

OHSU contributed to a special issue of Health Psychology that describes ways to influence behavioral change.

In a story regarding an uptick in outdoor recreation areas this summer due to the coronavirus pandemic, Carlos Crespo, Ph.D., says many other diseases can be transmitted outdoors and there’s no reason to this the coronavirus is any different.

Eric Simpson, M.D., says findings from recent studies involving tralokinumab could suggest a path forward for the drug’s use to treat eczema.